Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

Exploration of the mechanisms by which 3,4-benzopyrene promotes angiotensin II-induced abdominal aortic aneurysm formation in mice.

Ji K, Zhang Y, Jiang F, Qian L, Guo H, Hu J, Liao L, Tang J.

J Vasc Surg. 2014 Feb;59(2):492-9. doi: 10.1016/j.jvs.2013.03.022. Epub 2013 May 12.

2.

Zoledronate attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of Rho/ROCK-dependent JNK and NF-κB pathway.

Tsai SH, Huang PH, Peng YJ, Chang WC, Tsai HY, Leu HB, Chen JW, Lin SJ.

Cardiovasc Res. 2013 Dec 1;100(3):501-10. doi: 10.1093/cvr/cvt230.

PMID:
24225494
3.
4.

Ginsenoside Rb1 attenuates angiotensin II-induced abdominal aortic aneurysm through inactivation of the JNK and p38 signaling pathways.

Zhang XJ, He C, Tian K, Li P, Su H, Wan JB.

Vascul Pharmacol. 2015 Oct;73:86-95. doi: 10.1016/j.vph.2015.04.003. Epub 2015 Apr 22.

PMID:
25912763
5.

Peptide inhibitor of CXCL4-CCL5 heterodimer formation, MKEY, inhibits experimental aortic aneurysm initiation and progression.

Iida Y, Xu B, Xuan H, Glover KJ, Tanaka H, Hu X, Fujimura N, Wang W, Schultz JR, Turner CR, Dalman RL.

Arterioscler Thromb Vasc Biol. 2013 Apr;33(4):718-26. doi: 10.1161/ATVBAHA.112.300329. Epub 2013 Jan 3.

6.

Azelnidipine suppresses the progression of aortic aneurysm in wild mice model through anti-inflammatory effects.

Kurobe H, Matsuoka Y, Hirata Y, Sugasawa N, Maxfield MW, Sata M, Kitagawa T.

J Thorac Cardiovasc Surg. 2013 Dec;146(6):1501-8. doi: 10.1016/j.jtcvs.2013.02.073. Epub 2013 Mar 25.

7.

Locally applied leptin induces regional aortic wall degeneration preceding aneurysm formation in apolipoprotein E-deficient mice.

Tao M, Yu P, Nguyen BT, Mizrahi B, Savion N, Kolodgie FD, Virmani R, Hao S, Ozaki CK, Schneiderman J.

Arterioscler Thromb Vasc Biol. 2013 Feb;33(2):311-20. doi: 10.1161/ATVBAHA.112.300543. Epub 2012 Dec 6.

8.

Deficiency of cathepsin S attenuates angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-deficient mice.

Qin Y, Cao X, Guo J, Zhang Y, Pan L, Zhang H, Li H, Tang C, Du J, Shi GP.

Cardiovasc Res. 2012 Dec 1;96(3):401-10. doi: 10.1093/cvr/cvs263. Epub 2012 Aug 7.

9.

Cigarette smoking increases aortic dilatation without affecting matrix metalloproteinase-9 and -12 expression in a modified mouse model of aneurysm formation.

Bergoeing MP, Arif B, Hackmann AE, Ennis TL, Thompson RW, Curci JA.

J Vasc Surg. 2007 Jun;45(6):1217-1227. Epub 2007 Mar 29.

10.

Regulatory T cells prevent angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E knockout mice.

Meng X, Yang J, Zhang K, An G, Kong J, Jiang F, Zhang Y, Zhang C.

Hypertension. 2014 Oct;64(4):875-82. doi: 10.1161/HYPERTENSIONAHA.114.03950. Epub 2014 Jul 14.

11.

Free-radical scavenger edaravone inhibits both formation and development of abdominal aortic aneurysm in rats.

Morimoto K, Hasegawa T, Tanaka A, Wulan B, Yu J, Morimoto N, Okita Y, Okada K.

J Vasc Surg. 2012 Jun;55(6):1749-58. doi: 10.1016/j.jvs.2011.11.059. Epub 2012 Feb 15.

12.

Effects of chymase inhibitor on angiotensin II-induced abdominal aortic aneurysm development in apolipoprotein E-deficient mice.

Inoue N, Muramatsu M, Jin D, Takai S, Hayashi T, Katayama H, Kitaura Y, Tamai H, Miyazaki M.

Atherosclerosis. 2009 Jun;204(2):359-64. doi: 10.1016/j.atherosclerosis.2008.09.032. Epub 2008 Oct 8.

PMID:
18996524
13.

Inhibition of experimental abdominal aortic aneurysm in a rat model by the angiotensin receptor blocker valsartan.

Fujiwara Y, Shiraya S, Miyake T, Yamakawa S, Aoki M, Makino H, Nishimura M, Morishita R.

Int J Mol Med. 2008 Dec;22(6):703-8.

PMID:
19020766
14.

Importance of endothelial NF-κB signalling in vascular remodelling and aortic aneurysm formation.

Saito T, Hasegawa Y, Ishigaki Y, Yamada T, Gao J, Imai J, Uno K, Kaneko K, Ogihara T, Shimosawa T, Asano T, Fujita T, Oka Y, Katagiri H.

Cardiovasc Res. 2013 Jan 1;97(1):106-14. doi: 10.1093/cvr/cvs298. Epub 2012 Sep 26.

PMID:
23015640
15.

Role of vascular endothelial growth factor-A in development of abdominal aortic aneurysm.

Kaneko H, Anzai T, Takahashi T, Kohno T, Shimoda M, Sasaki A, Shimizu H, Nagai T, Maekawa Y, Yoshimura K, Aoki H, Yoshikawa T, Okada Y, Yozu R, Ogawa S, Fukuda K.

Cardiovasc Res. 2011 Jul 15;91(2):358-67. doi: 10.1093/cvr/cvr080. Epub 2011 Mar 24.

PMID:
21436157
16.

Interleukin-5 is a potential mediator of angiotensin II-induced aneurysm formation in apolipoprotein E knockout mice.

Xu J, Ehrman B, Graham LM, Eagleton MJ.

J Surg Res. 2012 Nov;178(1):512-8. doi: 10.1016/j.jss.2011.12.016. Epub 2012 Mar 10.

17.

Resveratrol prevents the development of abdominal aortic aneurysm through attenuation of inflammation, oxidative stress, and neovascularization.

Kaneko H, Anzai T, Morisawa M, Kohno T, Nagai T, Anzai A, Takahashi T, Shimoda M, Sasaki A, Maekawa Y, Yoshimura K, Aoki H, Tsubota K, Yoshikawa T, Okada Y, Ogawa S, Fukuda K.

Atherosclerosis. 2011 Aug;217(2):350-7. doi: 10.1016/j.atherosclerosis.2011.03.042. Epub 2011 Apr 8.

PMID:
21530968
18.

Smooth muscle cell deletion of low-density lipoprotein receptor-related protein 1 augments angiotensin II-induced superior mesenteric arterial and ascending aortic aneurysms.

Davis FM, Rateri DL, Balakrishnan A, Howatt DA, Strickland DK, Muratoglu SC, Haggerty CM, Fornwalt BK, Cassis LA, Daugherty A.

Arterioscler Thromb Vasc Biol. 2015 Jan;35(1):155-62. doi: 10.1161/ATVBAHA.114.304683. Epub 2014 Nov 13.

19.

Hyperglycemia limits experimental aortic aneurysm progression.

Miyama N, Dua MM, Yeung JJ, Schultz GM, Asagami T, Sho E, Sho M, Dalman RL.

J Vasc Surg. 2010 Oct;52(4):975-83. doi: 10.1016/j.jvs.2010.05.086. Epub 2010 Aug 3.

20.

Vitamin E inhibits abdominal aortic aneurysm formation in angiotensin II-infused apolipoprotein E-deficient mice.

Gavrila D, Li WG, McCormick ML, Thomas M, Daugherty A, Cassis LA, Miller FJ Jr, Oberley LW, Dellsperger KC, Weintraub NL.

Arterioscler Thromb Vasc Biol. 2005 Aug;25(8):1671-7. Epub 2005 Jun 2.

Supplemental Content

Support Center